News
GlucaGen HypoKit shortage extended by one month
The TGA has been notified of an extended shortage for GlucaGen HypoKit.
The Therapeutic Goods Administration (TGA) has provided an update on the shortage period for GlucaGen HypoKit.
Novo Nordisk has submitted an updated shortage notification to the TGA, extending the shortage period until 31 October 2023. This notification has been published on the TGA’s Medicine Shortages Reports Database.
The TGA has also published a web alert on their website regarding this extension.
